Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Discovery Diabetes

Discovery Diabetes: A Pilot Randomized Controlled Trial

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main questions it aims to answer are: Does the Discovery Program lead to better glycemic control as measured by HbA1c levels? How does participation in the Discovery Program affect diabetes distress and self-management skills? Researchers will compare participants in the Discovery Program to those receiving standard diabetes care to see if the program has a positive effect on diabetes management. Participants will: Engage in a 3-month intervention that includes personalized mobile health communications and clinician support. Complete surveys and assessments at the beginning of the study, and again at 3 and 6 months. Allow the study team to access their electronic health records for additional data on diabetes management.

Who May Be Eligible (Plain English)

Who May Qualify: - Adolescents (13-17 years) and young adults (aged 18-21 years), - Diagnosed with T1D for at least one year, - Access to a smartphone, - A My Health at Vanderbilt (MHAV) patient portal account, - Ability to read, speak, and understand English, - An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact Who Should NOT Join This Trial: - Diagnosis of type 2 diabetes - Any physical, cognitive, sensory or emotional condition precluding participation in the intervention (seeing/using a phone, hearing digital stories, answering questions). Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adolescents (13-17 years) and young adults (aged 18-21 years), * Diagnosed with T1D for at least one year, * Access to a smartphone, * A My Health at Vanderbilt (MHAV) patient portal account, * Ability to read, speak, and understand English, * An appointment with an NP in the VUMC Eskind Clinic within 7 months of initial contact Exclusion Criteria: * Diagnosis of type 2 diabetes * Any physical, cognitive, sensory or emotional condition precluding participation in the intervention (seeing/using a phone, hearing digital stories, answering questions).

Treatments Being Tested

BEHAVIORAL

Discovery Program

The Discovery Program is a novel, hybrid intervention specifically designed to address the psychosocial barriers faced by adolescents and young adults with T1D. This intervention integrates three key components: 1. Patient-Reported Measures 2. In-Clinic Collaborative Goal Setting 3. Personalized Mobile Health Communications The Discovery Program will be delivered over a 3-month intervention period, followed by a 6-month follow-up to assess outcomes. This approach not only aims to improve glycemic control but also seeks to enhance diabetes self-management behaviors, reduce diabetes distress, and build problem-solving skills among participants. The integration of clinical informatics, personalized support, and mobile health technology distinguishes this intervention from traditional diabetes care practices, which often overlook psychosocial factors affecting health outcomes.

Locations (1)

Vanderbilt University
Nashville, Tennessee, United States